Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-21-055531

Options or other derivatives

  • Chief Financial Officer acquired 215,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Byam Rebecca · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-08-29 Grant or award : show line 1 in the form Stock Option (Right to Buy) +135,000 135,000 D
2021-09-08 Grant or award : show line 2 in the form Stock Option (Right to Buy) +80,000 80,000 D
Loading xslF345X03/doc4.xml…